Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Beloranib

An Efficacy, Safety and Pharmacokinetics Study of Beloranib (ZGN-440 for Injectable Suspension) in Obese Subjects

Zafgen · Phase 2 · Completed · Enrollment 160

NCT01666691

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebon/rn/rn/rn/rn/r
0.3 mg Beloranibn/rn/rn/rn/rn/r
0.6 mg Beloranibn/rn/rn/rn/rn/r
1.2 mg Beloranibn/rn/rn/rn/rn/r
2.4 mg Beloranibn/rn/rn/rn/rn/r
3.2 mg Beloranibn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.